biotech
Bio-AnalystSupplement research
person

Psyllium

Digestion and gut health

Partial research summary

Human studies reported between-group improvement in Constipation symptoms.

Single-ingredient studies · Human studies · Includes patient groups · between-group comparison

Publications for this result: 2 (1 awaiting review included)

Other outcomes and study details

Distinct publications linked to this topic: 9

  • Study conditions differ; results are shown descriptively and are not pooled.
  • Some publications have not cleared source or interpretation review.
  • Some papers could not be reviewed, so this summary covers only findings that could be confirmed.

What has been studied?

Distinct human comparison papers: 2

  • Bristol stool scale score

    • Comparison result:A better result than the comparison group was reported.
      Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Unspecified population
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • Constipation symptoms

    • Comparison result:A better result than the comparison group was reported.
      Patient group · Single ingredient
      Measurement and study conditions
      • Controlled human study
      • Randomized trial
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Timepoint: unspecified
      • Study comparison: unspecified
  • Stool frequency

    Research with unclear study subject or type
    • A change was reported, but the comparison could not be confirmed.
      Patient group · Single ingredient
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Single ingredient
      • Patient group
      • Outcome role not specified
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: unspecified
    • The study reported improvement in this measurement.
      Patient group
      Measurement and study conditions
      • Meta-analysis
      • Meta-analysis
      • Unknown intervention
      • Patient group
      • Outcome role not specified
      • Between-group comparison
      • Study subject not identified
      • Timepoint: unspecified
      • Study comparison: unspecified
  • symptoms

    Other human research, including observational studies and reviews
    • A change was reported before and after use. Its cause cannot be isolated.
      Patient group · Single ingredient
      Measurement and study conditions
      • Other evidence
      • Clinical trial
      • Single ingredient
      • Patient group
      • Primary outcome
      • Within-group comparison
      • Timepoint: unspecified
      • Study comparison: symptom relief described after psyllium; placebo comparison is reported for microbiota but no compar

This result is held for interpretation. That does not mean research found no effect.

Outcome groups needing additional review (1)
  • small bowel obstruction · Distinct papers needing additional review: 1Direction unclear: 1

One paper can appear under multiple measured outcomes or review reasons, so these counts should not be added together.

Research topics to explore

Research topics to explore

Review findings reported in each research area.

Topics with more linked papers appear first.

  • Blood lipids

    Related papers 23 · human comparison papers 8

    View results
    • LDL cholesterol · Study conditions differ · Some studies included patients or people with a deficiency
    • plasma LDL-cholesterol concentration · Improvement reported

    More outcome groups: 7

  • Glucose and metabolic health

    Related papers 17 · human comparison papers 5

    View results
    • Body weight · Improvement reported · Some studies used more than one ingredient · Some studies included patients or people with a deficiency
    • Fasting blood sugar · Improvement reported · Some studies included patients or people with a deficiency

    More outcome groups: 10

  • Digestion and gut health

    Related papers 9 · human comparison papers 2

    View selected result
  • Blood pressure and vascular health

    Related papers 2 · comparison findings need further review

    View results
    • Systolic blood pressure · Some studies included patients or people with a deficiency · Comparison details unconfirmed
  • Exercise performance

    Related papers 1 · comparison findings need further review

    View results
Data coverage and detailed study classifications

Paper counts are separated by research topic below. One paper may contribute to multiple findings.

Analysis status: Public-ready

Ingredient analysis date:

How the grade was determined: B

The 65.0 evidence score includes 1 independent human studies and 1 clinical studies in the representative benefit area. The B tier remains conservative because of limited repetition across independent human clinical studies, too few clinical findings with an explicit effect direction.

The grade is based mainly on the research area with the most evidence. It does not mean the same result was found in other areas.

Papers linked to this ingredient overall: 84

Papers linked to this topic 9 · distinct papers 9 · papers with a confirmed human comparison 2 · papers needing additional review 4

Ingredient-wide papers, topic-linked papers, and sources in outcome groups use different scopes. Adding source counts may count the same paper more than once.

  • Bristol stool scale score: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 1
  • Constipation symptoms: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 1
  • small bowel obstruction: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0
  • Stool frequency: Sources represented in this measurement group: 2 · Distinct papers with human comparisons for this outcome: 0
  • symptoms: Sources represented in this measurement group: 1 · Distinct papers with human comparisons for this outcome: 0

Blood lipids

What the research found

serum total, LDL, and HDL cholesterol

Results for this measurement were mixed; no consistent conclusion can be drawn.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Total cholesterol

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL cholesterol

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL-C

The study reported improvement in this measurement.

Controlled study in people · Separable contribution · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL-C

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

plasma LDL-cholesterol concentration

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

ratio of total cholesterol to high-density lipoprotein cholesterol

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

serum total cholesterol

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

TC levels

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

serum total cholesterol

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL cholesterol

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Serum cholesterol concentration

A change was reported, but the comparison could not be confirmed.

Other evidence · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Cholesterol

The study needs further checking before its result can be interpreted.

Review · Single ingredient · Unspecified population

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

LDL-C

The study needs further checking before its result can be interpreted.

Controlled study in people · Separable contribution · General population

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

5 papers · 5 measured outcomes

5 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Glucose and metabolic health

What the research found

Body weight

The study reported improvement in this measurement.

Controlled study in people · Ingredient combination · Patient group

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fasting blood sugar

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HbA1c

A change was reported before and after use. Its cause cannot be isolated.

Controlled study in people · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HbA1c

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Insulin

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HbA1c

The study reported improvement in this measurement.

Meta-analysis · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HOMA IR

The study reported improvement in this measurement.

Meta-analysis · Single ingredient · General population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

HOMA-IR

The study reported improvement in this measurement.

Meta-analysis · Unknown intervention · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Body weight

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

2 papers · 2 measured outcomes

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Fasting blood glucose

A change was reported, but the comparison could not be confirmed.

Other evidence · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

fasting insulin level

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

insulin and glucose responses

A change was reported, but the comparison could not be confirmed.

Review · Unknown intervention · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Lower GIs

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Ingredient combination · Unspecified population

Several ingredients were used together. This does not establish the effect of this ingredient alone or synergy.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

plasma glucose

A change was reported, but the comparison could not be confirmed.

Controlled study in people · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

plasma glucose concentration

A change was reported in animal or cell research.

Animal study · indirect · Single ingredient · Patient group

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

2 papers · 2 measured outcomes

2 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Meta-analysis · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 2 measured outcomes

1 papers held from direction counts

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Digestion and gut health

What the research found

Bristol stool scale score

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Unspecified population

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Constipation symptoms

The study reported improvement in this measurement.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

stool frequency

The study reported improvement in this measurement.

Meta-analysis · Unknown intervention · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

symptoms

A change was reported before and after use. Its cause cannot be isolated.

Other evidence · Single ingredient · Patient group

Within-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Stool frequency

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

constipation symptoms

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

small bowel obstruction

The study needs further checking before its result can be interpreted.

Other evidence · Single ingredient · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Controlled study in people · Single ingredient · Patient group

Between-group comparison

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Cell study · indirect · Unknown intervention · Unspecified population

This finding comes from animal or cell research. It does not establish the same effect in people.

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Blood pressure and vascular health

What the research found

Systolic blood pressure

A change was reported, but the comparison could not be confirmed.

Meta-analysis · Single ingredient · Unspecified population

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Systolic blood pressure

A change was reported, but the comparison could not be confirmed.

Review · Single ingredient · Patient group

Analysis coverage and paper counts

1 paper · 1 measured outcome

Review overlap with primary papers is unknown; counts stay separate.

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

Exercise performance

What the research found

Unspecified measured outcome

The study needs further checking before its result can be interpreted.

Other evidence · Separable contribution · Patient group

The comparison could not be confirmed.

Analysis coverage and paper counts

1 paper · 1 measured outcome

1 papers held from direction counts

Direction counts are distinct papers within each row. Outcome contributions count endpoint results, so one paper may contribute more than once.

How to read research findings

How should I read research findings?

Research guides

Side effects and combination findings

Findings from this ingredient alone are shown separately from those involving another supplement or medication.

Caution findings
2
Findings from individual and combined use, plus reviewed cautions
Key precautions
No reviewed caution rules are available yet. Reported caution findings are shown below.
These findings were reported in studies. They do not predict an individual's experience.

Findings to review with care

Side effects reported for the ingredient alone are separated from findings involving another supplement or medication.

Side effects reported with this ingredient alone

Symptoms or adverse events reported in studies without another active ingredient.

small bowel obstruction1 papers
Four patients experienced small bowel obstruction after oral psyllium seed husk use as a contrast agent.Human studies · Study type not identified
Intestinal obstruction1 papers
Psyllium ingestion without adequate fluids caused intestinal obstruction in a 21‑year‑old man.Human studies · Observational study